Literature DB >> 1406927

Alzheimer's disease. In search of the soluble.

J Hardy, M Mullan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1406927     DOI： 10.1038/359268a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 2.  Transgenic animals as models for human disease--report of an EC Study Group.

Authors:  R Lathe; J J Mullins
Journal:  Transgenic Res       Date:  1993-09       Impact factor: 2.788

3.  Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Authors:  M Citron; C Vigo-Pelfrey; D B Teplow; C Miller; D Schenk; J Johnston; B Winblad; N Venizelos; L Lannfelt; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

4.  Serum alpha 1-antitrypsin and alpha 2-macroglobulin in Alzheimer's and Binswanger's disease.

Authors:  T Wetterling; K F Tegtmeyer
Journal:  Clin Investig       Date:  1994-02

5.  CNI-1493 inhibits Abeta production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease.

Authors:  Michael Bacher; Richard Dodel; Bayan Aljabari; Kathy Keyvani; Philippe Marambaud; Rakez Kayed; Charles Glabe; Nicole Goertz; Anne Hoppmann; Norbert Sachser; Jens Klotsche; Susanne Schnell; Lars Lewejohann; Yousef Al-Abed
Journal:  J Exp Med       Date:  2008-06-23       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.